These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27659878)

  • 21. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.
    Welch M; Uslan DZ; Greenspon AJ; Sohail MR; Baddour LM; Blank E; Carrillo RG; Danik SB; Del Rio A; Hellinger W; Le KY; Miro JM; Naber C; Peacock JE; Vikram HR; Tseng CH; Prutkin JM;
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):955-62. PubMed ID: 24665867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT Trial.
    Tarakji KG; Krahn AD; Poole JE; Mittal S; Kennergren C; Biffi M; Korantzopoulos P; Dallaglio PD; Lexcen DR; Lande JD; Hilleren G; Holbrook R; Wilkoff BL
    JACC Clin Electrophysiol; 2022 Jan; 8(1):101-111. PubMed ID: 34600848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England.
    Boriani G; Kennergren C; Tarakji KG; Wright DJ; Ahmed FZ; McComb JM; Goette A; Blum T; Biffi M; Green M; Shore J; Carion PL; Wilkoff BL
    Value Health; 2021 Jul; 24(7):930-938. PubMed ID: 34243836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular implantable electronic device associated infections.
    Gandhi T; Crawford T; Riddell J
    Infect Dis Clin North Am; 2012 Mar; 26(1):57-76. PubMed ID: 22284376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
    Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcome of Cardiovascular Implantable Electronic Device Infections in Turkey.
    Aydin M; Yildiz A; Kaya Z; Kaya Z; Basarir AO; Cakmak N; Donmez I; Morrad B; Avci A; Demir K; Cagliyan EC; Yuksel M; Elbey MA; Kayan F; Ozaydogdu N; Islamoglu Y; Cayli M; Alan S; Ulgen MS; Ozhan H
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):459-64. PubMed ID: 25589093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).
    Greenspon AJ; Prutkin JM; Sohail MR; Vikram HR; Baddour LM; Danik SB; Peacock J; Falces C; Miro JM; Blank E; Naber C; Carrillo RG; Tseng CH; Uslan DZ
    J Am Coll Cardiol; 2012 Feb; 59(7):681-7. PubMed ID: 22322085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
    Margey R
    J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
    Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
    Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE project.
    Ziacchi M; Biffi M; Iacopino S; di Silvestro M; Marchese P; Miscio F; Caccavo VP; Zanotto G; Tomasi L; Dello Russo A; Donazzan L; Boriani G
    Europace; 2023 Nov; 25(11):. PubMed ID: 37490930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations.
    Callahan TD; Tarakji KG; Wilkoff BL
    Europace; 2021 Jun; 23(23 Suppl 4):iv28-iv32. PubMed ID: 34160597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diagnostic pathways urgently needed. Protocol of PET Guidance I pilot study: positron emission tomography in suspected cardiac implantable electronic device-related infection.
    Marciniak-Emmons MB; Sterliński M; Syska P; Maciąg A; Farkowski MM; Firek B; Dziuk M; Zając D; Pytkowski M; Szwed H
    Kardiol Pol; 2016; 74(1):47-52. PubMed ID: 26101020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
    Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
    Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.